Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Trondheim – page 10

195 clinical trials in Trondheim, Norway across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Trondheim at a glance
195
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

195 trials in Trondheim

Open in trial search

Endometrial cancer

Not yet recruiting

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:GSK5733584
  • Sponsor:Glaxosmithkline Research & Development Limited

Non-small cell lung cancer

Not yet recruiting

Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Oslo University Hospital HF

Coronary artery disease

Not yet recruiting

Continuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Vestre Viken HF

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Retinopathy of prematurity

Not yet recruiting

Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:St. Olavs Hospital HF

Type IIa hyperlipidaemia

Not yet recruiting

Atorvastatin, Placebo, and No Treatment in Adults with Familial Hypercholesterolaemia and Statin-Associated Muscle Symptoms

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Oslo University Hospital HF

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC

Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

Not yet recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Cluster headache

Not yet recruiting

A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Cluster headache

Not yet recruiting

A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Type 1 diabetes mellitus

Not yet recruiting

A study evaluating a combination of glucagon and insulin lispro to improve insulin absorption in adults with Type 1 diabetes

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glucagon
  • Sponsor:St. Olavs Hospital HF

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Trondheim

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials investigating treatments for various cancer types, including pancreatic ductal cancer, gastric cancer, and follicular lymphoma. Studies focus on evaluating new therapeutic combinations and precision medicine approaches.

  • Targeted therapies for HER2-positive cancers
  • Pediatric liver tumors
  • Breast cancer personalized treatment

Multiple trials are exploring immunotherapy combinations and novel drug applications for improved patient outcomes.

02 Neurological Disorders

Research focusing on innovative treatments for Alzheimer's disease and brain tumors. Studies include evaluation of new drug combinations and comparative effectiveness of existing therapies.

  • Early-stage Alzheimer's interventions
  • Glioblastoma treatment strategies
  • Meningioma therapeutic approaches

Trials aim to improve patient outcomes through targeted therapeutic interventions and biomarker studies.

03 Respiratory and Infectious Diseases

Studies examining treatments for chronic wet cough in children and respiratory infections. Research includes antibiotic efficacy trials and innovative treatment approaches.

  • Pediatric respiratory infections
  • Antibiotic effectiveness studies
  • Wheezing prevention in children

Focus on developing evidence-based treatment protocols for respiratory conditions in pediatric populations.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.